Jan 28, 2022 US Securities Fraud Liability for Non-US Issuers of Securities Subject to Unsponsored ADRs: New Ruling Opens Up Additional Defense Strategies By Linda Martin David Livshiz Doru Gavril Henry Hutten +1 more... Show less Non-US issuers of securities with unsponsored ADRs in US capital markets may have gained a new defense strategy, a federal court in Los...
Jan 25, 2022 US Antitrust Merger Control: New Guidelines for Modern Competition By Meghan Rissmiller Justin Stewart-Teitelbaum Laura Onken Ahmad Al Dajani +1 more... Show less On Tuesday, January 18, 2022, the United States Federal Trade Commission (FTC) and Department of Justice Antitrust Division (DOJ)...
Jan 25, 2022 The Federal Reserve Solicits Ideas on a U.S. Central Bank Digital Currency By Brock Dahl Francesca Loreto On January 20, 2022 the Federal Reserve Board published a paper that it described as the first step in a public discussion between the...
Jan 24, 2022 Is it time for big biopharma companies to rethink the use of federal funding for R&D? By Kristen Riemenschneider This article was originally published in STAT on January 18, 2022. I have been negotiating with representatives of the federal government...
Jan 24, 2022 2021 De-SPAC Debrief By Michael Levitt Valerie Ford Jacob Sebastian Fain Pamela Marcogliese Paul Tiger Andrea Basham +3 more... Show less We’re pleased to announce Freshfields’ 2021 De-SPAC Debrief: A comprehensive review of all de-SPAC transactions that closed in 2021. 2021...
Jan 24, 2022 Freshfields Team Authors Anti-Corruption Practice Guide By Eric Bruce Justin Simeone Andrew Bulovsky Amid active anti-corruption efforts by US and foreign authorities in recent years, the Biden administration emphasized during 2021 that...
Jan 19, 2022 Distressed Financing Pitfalls: When Execution Goes Off Track (Part 4) By Samantha Braunstein Lacey Nemergut In Parts 1, 2 and 3 we covered some easy traps to fall into when trying to execute a distressed financing transaction but we can’t stop...
Jan 14, 2022 Freshfields partner and co-head of US Corporate and M&A Ethan Klingsberg talks M&A in 2022 with Bloomberg TV By Ethan Klingsberg Partner and co-head of US Corporate and M&A Ethan Klingsberg recently appeared on Bloomberg Markets: The Close to discuss what he sees as...
Jan 14, 2022 There’s a new CFIUS Excepted Foreign State, but status will still benefit relatively few investors By Aimen Mir Christine Laciak Colin Costello Qualifying investors from a list of “Excepted Foreign States” (colloquially referred to as the “whitelist”) enjoy certain privileges...
Jan 13, 2022 Ten key medtech themes for 2022 By Vinita Kailasanath Nida Rais The COVID-19 pandemic has accelerated the transformation of business models in the life sciences industry, with digital initiatives...
Jan 12, 2022 M&A predictions for 2022: where the tensions, the action and the hot spots will be and why By Ethan Klingsberg As the 2022 pipeline continues to flow, here’s a quick preview of where the tensions, action and hot spots will be in M&A this year,...
Jan 11, 2022 Delaware Chancery Court Issues First SPAC Decision By Mary Eaton Sebastian Fain Michael Levitt Nicholas Caselli +1 more... Show less In a much-anticipated decision, the Delaware Court of Chancery issued its first opinion involving shareholder challenges to de-SPAC...